Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Pfizer launches chronic pain forum

Twitter style comments are used to help patients describe their conditions

- PMLiVE

EMA starts contraceptive safety probe

Follows French investigation into Bayer’s Diane 35

- PMLiVE

Biogen Idec posts solid Q4 results and says more to come

MS drugs Tysabri and Avonex lift sales

- PMLiVE

Draftfcb New York announces internal re-shuffle

Dana Maiman to focus on Draftfcb Healthcare as agency steps up its healthcare offering

EISAI

Eisai expands into South Africa

Files Halaven and Fycompa for approval

- PMLiVE

Succinct forms market access partnership with Royal Marsden

Agency aims is to tackle non-financial issues relating to new medicines

- PMLiVE

Boehringer launches COPD patient consultation app for HCPs

Extends reach of the calculator tools on its COPD Exchange website

- PMLiVE

Endo to collaborate with India-based CRO GVK Biosciences

Will develop small molecule against undisclosed target in pain

- PMLiVE

Kantar Health appoints two senior researchers

Dr Theano Anasta and Svetlana Gogolina join research firm

Lonafarnib: promising results in first-ever trial for progeria

Treatments for progeria are limited but lonafarnib and FTIs as a class have given renewed hope for children with the condition

New marcomms agency opens in London’s Tech City

Couch is developing a client list from across pharma, private and public sectors

- PMLiVE

France investigates Bayer’s acne drug Diane 35 after deaths

Linked to blood clots in women

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links